AlphaMark Advisors »

Intra Cellular Therapies shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $289k 4.2k 68.50

More positions owned by AlphaMark Advisors

AlphaMark Actively Man Etf (SMCP)
iShares S&P 500 Etf (IVV)
Procter & Gamble Company (PG)
Technology SPDR Etf (XLK)
Health Care SPDR Etf (XLV)
SPDR Trust Unit SR Etf (SPY)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Db-x Msci Eafe Currency-hedged (DBEF)
Financial Select Sector SPDR (XLF)
Janus Detroit Str Tr (JAAA)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Industrial SPDR (XLI)
Energy SPDR Etf (XLE)
Comms Svcs Sel SPDR Etf (XLC)
Consumer Staples Select Sect. SPDR (XLP)

View all positions for AlphaMark Advisors

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Daniel D. Thurber
Jpmorgan Chase & Co
Invesco
venBio Select Advisor
Bellevue Group
State Street Corporation
ClearBridge Advisors
Perceptive Advisors
Geode Capital Management
Wellington Management Company
Franklin Resources
Suvretta Capital Management

View all funds holding Intra Cellular Therapies